Last reviewed · How we verify

NCT03792789

Evaluation of Repetitive Transcranial Magnetic Stimulation as an Adjunct to Modified Constraint Induced Movement Therapy in Improving Upper Limb Function in Children With Hemiparetic Cerebral Palsy Aged 5 - 18 Years

Status unknown NA Last updated 3 January 2019
What this trial tests

NA trial testing mCIMT with real rTMS in Hemiparetic Cerebral Palsy in 40 participants. Status unknown.

Timeline
15 January 2019
Primary endpoint
1 August 2020
30 August 2020

Quick facts

Lead sponsorAll India Institute of Medical Sciences
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date15 January 2019
Primary completion1 August 2020
Estimated completion30 August 2020
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

All India Institute of Medical Sciences

Who can join

Adults 5 to 18, any sex, with Hemiparetic Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim to evaluate efficacy of TMS as an adjunct to CIMT, assess its safety and tolerability and study cortical excitability with help of TMS which are both rehabilitative therapies for hemiplegic cerebral palsy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Brain Stimulation and Constraint Induced Movement Therapy in Children With Unilateral Cerebral Palsy: A Randomized Controlled Trial.
    Gupta J, Gulati S, Singh UP, Kumar A, et al · · 2023 · cited 10× · PMID 37170480 · DOI 10.1177/15459683231174222

Verify or expand the search:

Other recruiting trials for Hemiparetic Cerebral Palsy

Currently open trials in the same condition.

Other All India Institute of Medical Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03792789.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing